0000893750-12-000039.txt : 20120410 0000893750-12-000039.hdr.sgml : 20120410 20120410171547 ACCESSION NUMBER: 0000893750-12-000039 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20120410 DATE AS OF CHANGE: 20120410 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001484478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271197863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85529 FILM NUMBER: 12752521 BUSINESS ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-456-7800 MAIL ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: PPD Therapeutics, Inc. DATE OF NAME CHANGE: 20100218 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Invus Public Equities, LP CENTRAL INDEX KEY: 0001340097 IRS NUMBER: 980420215 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 135 EAST 57, 30 TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-317-7520 MAIL ADDRESS: STREET 1: 135 EAST 57, 30 TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 SC 13G/A 1 sch13ga.htm SCHEDULE 13G/A - FURIEX PHARMACEUTICALS, INC. sch13ga.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
 
Under the Securities Exchange Act of 1934
 
(Amendment No. 2)*
 

FURIEX PHARMACEUTICALS, INC.
(Name of Issuer)

Common Stock, par value $0.001 per share
(Title of Class of Securities)

36106P101
(CUSIP Number)

March 31, 2012
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[   ]  Rule 13d-1(b)
[X]  Rule 13d-1(c)
[   ]  Rule 13d-1(d)
 

*  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

 
 
 

Page 1
 
 
 
 

 
 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Invus Public Equities, L.P.
 
 
 
2.
Check the Appropriate Box if a Member of a Group                                                (a)  [  ]
         
                                                                 (b)  [  ]
 
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  Bermuda
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  PN
 
 

 
 

 
Page 2
 
 
 


 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Invus Public Equities Advisors, LLC
 
 
2.
Check the Appropriate Box if a Member of a Group                                                 (a)  [  ]
         
                                                               (b)  [  ]
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  Delaware
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  OO
 
 

 
 

 

Page 3
 
 
 

 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Artal International S.C.A.
 
 
2.
Check the Appropriate Box if a Member of a Group                                               (a)  [  ]
         
                                                               (b)  [  ]
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  OO
 
 
 
 

 
Page 4
 
 
 

 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Artal International Management S.A.
 
 
2.
Check the Appropriate Box if a Member of a Group                                                 (a)  [  ]
         
                                                               (b)  [  ]
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  OO
 
 
 
 

 
Page 5
 
 
 

 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Artal Group S.A.
 
 
2.
Check the Appropriate Box if a Member of a Group                                                 (a)  [  ]
         
                                                               (b)  [  ]
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  OO
 
 


 
 

 
Page 6
 
 
 

 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Westend S.A.
 
 
2.
Check the Appropriate Box if a Member of a Group                                                 (a)  [  ]
         
                                                               (b)  [  ]
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  OO
 
 


 
 

 
Page 7
 
 
 

 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Stichting Administratiekantoor Westend
 
 
2.
Check the Appropriate Box if a Member of a Group                                                 (a)  [  ]
         
                                                               (b)  [  ]
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  The Netherlands
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  OO
 
 
 
 

 
Page 8
 
 
 

 
CUSIP No. 36106P101
 
 
13G
  
   
1.
Name of Reporting Persons:  Mr. Pascal Minne
 
 
2.
Check the Appropriate Box if a Member of a Group                                                 (a)  [  ]
         
                                                               (b)  [  ]
 
3.
SEC Use Only
 
 
4.
Citizenship or Place of Organization:  Belgium
 
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
 
6.
Shared Voting Power:  695,000
 
 
7.
Sole Dispositive Power:  0
 
 
8.
Shared Dispositive Power:  695,000
 
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  695,000
 
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[   ]
 
11.
Percent of Class Represented by Amount in Row (9):  7.0%
 
 
12.
Type of Reporting Person (See Instructions):  IN
 
 

 
 

 
Page 9
 
 
 
 

Item 1.
(a).  Name of Issuer
        Furiex Pharmaceuticals, Inc. (the “Issuer”)
(b).  Address of Issuer’s Principal Executive Offices:
        3900 Paramount Parkway, Suite 150, Morrisville, NC 27560
 
Item 2(a).
Item 2(b).
Item 2(c).
Name of Person Filing
Address of Principal Business Office
Citizenship
 
(i) Invus Public Equities, L.P. (“Invus Public Equities”)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Bermuda limited partnership
 
(ii) Invus Public Equities Advisors, LLC (“Invus Advisors”)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
 
(iii) Artal International S.C.A. (“Artal International”)
10-12 avenue Pasteur, L-2310 Luxembourg, Luxembourg
Citizenship: Luxembourg limited partnership
 
(iv) Artal International Management S.A. (“Artal International Management”)
10-12 avenue Pasteur, L-2310 Luxembourg, Luxembourg
Citizenship: Luxembourg société anonyme
 
(v) Artal Group S.A. (“Artal Group”)
10-12 avenue Pasteur, L-2310 Luxembourg, Luxembourg
Citizenship: Luxembourg société anonyme
 
(vi) Westend S.A. (“Westend”)
10-12 avenue Pasteur, L-2310 Luxembourg, Luxembourg
Citizenship: Luxembourg société anonyme
 
(vii) Stichting Administratiekantoor Westend (the “Stichting”)
De Boelelaan 7, NL-1083 HJ Amsterdam, The Netherlands
Citizenship: Netherlands foundation
 
(viii) Mr. Pascal Minne
Place Ste. Gudule, 19, B-1000 Bruxelles, Belgium
Citizenship: Belgium
 
The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.”
 
Item 2(d).
Title of Class of Securities:
 
Common Stock, par value $0.001 (the “Shares”)
 
Item 2(e).
CUSIP Number:  36106P101
 
 

 
 
 

 
Page 10
 
 
 
 

 
 
Item 3.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
This Item 3 is not applicable.
 
Item 4.
Ownership.
 
(a)  Amount beneficially owned:
 
As of April 10, 2012, each of the Reporting Persons may be deemed the beneficial owner of 695,000 Shares held for the account of Invus Public Equities.
 
(b)  Percent of class:
 
As of April 10, 2012, each of the Reporting Persons may be deemed the beneficial owner of approximately 7.0% of Shares outstanding. (There were 9,949,422 Shares outstanding as of February 29, 2012, according to the Issuer’s annual report on Form 10-K, filed March 7, 2012.)
 
(c)  Number of Shares as to which the Reporting Person has:
 
Invus Advisors, Artal International, Artal International Management, Artal Group, Westend, The Stichting and Mr. Minne:
 
(i)    Sole power to vote or to direct the vote:
0
(ii)   Shared power to vote or to direct the vote:
695,000
(iii)  Sole power to dispose or to direct the disposition of:
0
(iv)  Shared power to dispose or to direct the disposition of:
695,000
 
Item 5.
Ownership of Five Percent or Less of a Class
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [  ]
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
This Item 6 is not applicable.
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
 
This Item 7 is not applicable.
 
Item 8.
Identification and Classification of Members of the Group.
 
This Item 8 is not applicable.
 

 
 

 
Page 11
 
 
 
 
 
 
Item 9.
Notice of Dissolution of Group.
 
This Item 9 is not applicable.
 
Item 10.
Certification.
 
Each of the Reporting Persons hereby makes the following certification:
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 
 
 
Page 12
 
 
 
 
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
INVUS PUBLIC EQUITIES, L.P.
 
By: INVUS PUBLIC EQUITIES ADVISORS, LLC, its general partner
   
By:
  
/s/ Raymond Debbane
   
———————————————————————————————————————————————
Name:
  
Raymond Debbane
Title:
  
President
 
INVUS PUBLIC EQUITIES ADVISORS, LLC
   
By:
  
/s/ Raymond Debbane
   
———————————————————————————————————————————————
Name:
  
Raymond Debbane
Title:
  
President
 
ARTAL INTERNATIONAL S.C.A.
 
By: ARTAL INTERNATIONAL MANAGEMENT S.A., its managing partner
   
By:
  
/s/ Anne Goffard
   
———————————————————————————————————————————————
Name:
  
Anne Goffard
Title:
  
Managing Director
 
ARTAL INTERNATIONAL MANAGEMENT S.A.
   
By:
  
/s/ Anne Goffard
   
———————————————————————————————————————————————
Name:
  
Anne Goffard
Title:
  
Managing Director
 
ARTAL GROUP S.A.
   
By:
  
/s/ Anne Goffard
   
———————————————————————————————————————————————
Name:
  
Anne Goffard
Title:
  
Authorized Person
 
WESTEND S.A.
 
By:
  
/s/ Pascal Minne
   
———————————————————————————————————————————————
Name:
  
Pascal Minne
Title:
  
Director
 
STICHTING ADMINISTRATIEKANTOOR WESTEND
 
By:
  
/s/ Pascal Minne
   
———————————————————————————————————————————————
Name:
  
Pascal Minne
Title:
  
Sole Member of the Board
 
 

 
Page 13
 
 
 


MR. PASCAL MINNE
     
/s/ Pascal Minne
—————————————————————————————————————————————————————————
     
Dated: April 10, 2012

 
 

 
Page 14
 
 
 
 

EXHIBIT LIST

Exhibit 99.1
Amended and Restated Joint Filing Agreement, dated April 10, 2012.
 
 

 
Page 15
 

 

 
 
 
 
 EX-99.1 2 exh99_1.htm EXHIBIT 99.1 exh99_1.htm
 
Exhibit 99.1

AMENDED AND RESTATED JOINT FILING AGREEMENT
 
This Amended and Restated Joint Filing Agreement (this “Agreement”) amends and restates the Joint Filing Agreement, dated February 14, 2012, by and among Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Ulys, L.L.C. and Raymond Debbane.
 
The undersigned agree that the statement on Schedule 13G with respect to the Common Stock of Auxilium Pharmaceuticals, Inc., dated as of April 10, 2012, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
 
INVUS PUBLIC EQUITIES, L.P.
 
By: INVUS PUBLIC EQUITIES ADVISORS, LLC, its general partner
   
By:
  
/s/ Raymond Debbane
   
———————————————————————————————————————————————
Name:
  
Raymond Debbane
Title:
  
President
 
INVUS PUBLIC EQUITIES ADVISORS, LLC
   
By:
  
/s/ Raymond Debbane
   
———————————————————————————————————————————————
Name:
  
Raymond Debbane
Title:
  
President
 
ARTAL INTERNATIONAL S.C.A.
 
By: ARTAL INTERNATIONAL MANAGEMENT S.A., its managing partner
   
By:
  
/s/ Anne Goffard
   
———————————————————————————————————————————————
Name:
  
Anne Goffard
Title:
  
Managing Director
 
ARTAL INTERNATIONAL MANAGEMENT S.A.
   
By:
  
/s/ Anne Goffard
   
———————————————————————————————————————————————
Name:
  
Anne Goffard
Title:
  
Managing Director
 
ARTAL GROUP S.A.
   
By:
  
/s/ Anne Goffard
   
———————————————————————————————————————————————
Name:
  
Anne Goffard
Title:
  
Authorized Person

Page 1
 
 
 
 


WESTEND S.A.
 
By:
  
/s/ Pascal Minne
   
———————————————————————————————————————————————
Name:
  
Pascal Minne
Title:
  
Director
 
STICHTING ADMINISTRATIEKANTOOR WESTEND
 
By:
  
/s/ Pascal Minne
   
———————————————————————————————————————————————
Name:
  
Pascal Minne
Title:
  
Sole Member of the Board
     

MR. PASCAL MINNE
   
/s/ Pascal Minne
—————————————————————————————————————————————————————————
   
Dated: April 10, 2012

 

Page 2